Commercialization of Academic Research

Commercialization of Academic Research No doubt, there are abuses in commercialization of research at universities.1 I know of some, at universities and in industry. In two of these cases, academic researchers knew that the invention was stolen from them (in one instance by a small company, in another by a researcher in a different university), but they declined to take any action. Abuses may call for some improvements in the law or in procedures, but not for abandoning the system of protect

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

No doubt, there are abuses in commercialization of research at universities.1 I know of some, at universities and in industry. In two of these cases, academic researchers knew that the invention was stolen from them (in one instance by a small company, in another by a researcher in a different university), but they declined to take any action. Abuses may call for some improvements in the law or in procedures, but not for abandoning the system of protecting intellectual property.

I spent several interesting years at a medical diagnostics company (Technicon, since absorbed into Bayer), seeking out, funding, and licensing research at universities. Our objective, which was never hidden, was to use the results to expand our product line and markets. To do that required development and marketing investments much larger than the costs of the research, and we needed patents to justify the investments. Our contracts always gave the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Marvin Margoshes

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo